The structure-function relationship of glucose-dependent insulinotropic polypeptide
Glucose-dependent insulinotropic polypeptide or gastric inhibitory polypeptide (GIP) is a 42 amino acid endocrine gut hormone which exhibits several direct and indirect effects on fat and glucose metabolism. The first known, and most scrutinized, metabolic function of the hormone was the potentia...
Main Author: | |
---|---|
Language: | English |
Published: |
2009
|
Online Access: | http://hdl.handle.net/2429/7059 |
Summary: | Glucose-dependent insulinotropic polypeptide or gastric inhibitory polypeptide
(GIP) is a 42 amino acid endocrine gut hormone which exhibits several direct and
indirect effects on fat and glucose metabolism. The first known, and most
scrutinized, metabolic function of the hormone was the potentiation of insulin
release from pancreatic 13-cells in the presence of threshold glucose levels. In
order to determine the region(s) of the molecule involved in mediating the insulin
response at the beta cell, synthetic and proteolytic fragments of the molecule were
generated and tested for their ability to potentiate the insulin response in the
isolated, perfused rat pancreas. Previous work by others suggested that GIP amino
acids 15 to 30 might be necessaly for biological activity yet a synthetic 15-30
fragment was biologically-inactive. However, enterokinase treatment of a
synthetic 15 to 30 fragment restored approximately 30% of the integrated
insulinotropic activity over a 25 mm perfusion of the isolated rat pancreas. The
hypothesis that the restoration of biological activity was due to the enzymatic
removal of the amino terminus aspartic acid/lysine residues of 1G513P0 was
supported by the observation that a synthetic fragment lacking these two residues
was also insulinotropic. There was no apparent difference in the insulin responses
to the synthetic fragment or the enterokinase-derived fragment. Further
fractionation of the molecule generated a 19-30 fragment which was also
biologically active suggesting that the residues necessaiy for the insulin response
were contained within this region. Two recombinant prokaiyotic expression
systems for GIP were developed to further define the bioactive residues across the 19-30 region and to establish a system for the generation of large amounts of
biologically-active material. Site-directed mutagenesis of a recombinant GIP clone
was used to generate a full-length GIP molecule with alanine residues substituted
across the 23 to 26 region of the polypeptide. This substitution resulted in the loss
of biological activity suggesting that one or more of these residues is critical to the
insulin response. An innate intramolecular interaction associated with the
expression system precluded the isolation of sufficient quantities of alanine
substituted material in the 19-22 and 27-30 regions of the molecule. |
---|